Pharmacological Treatment of Depression

Principles and Practice of Geriatric Psychiatry: Third Edition

Volumn , Issue , 2010, Pages 537-542

  Abou Saleh, Mohammed T ^a   Katona, Cornelius ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antidepressant; Depressive disorder; Elderly; Mood stabiliser; Pharmacological treatment

Indexed keywords

EID: 84885763535     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470669600.ch86     Document Type: Chapter

References (67)

1. Patel V, Araya R, Chaterjee S et al. Treatment and prevention of mental disorders in low-income and middle-income countries. Lancet 2007; 370: 991-1005.
2. Dew MA, Reynolds CF III, Houck PR et al. Temporal profiles of the course of depression during treatment. Arch Gen Psychiatry 1997; 54: 1016-24.
3. Tadic A, Helmreich I Mergl R et al. Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression J Affect Disord 2010; 120: 86-93.
4. Catterson ML, Preskorn SH, Martin RM. Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology. Geriatr Psychiatry 1997; 20: 205-19.
5. Rajji TK, Mulsant BH, Lotrich FE, Lokker C and Reynolds CF Use of antidepressants in late-life depression. Drugs Aging 2008; 25(10): 841-53.
6. Rivard MFT. Pharmacotherapy of affective disorders in old age. Can J Psychiatry 1997; 42(suppl 1): 10-18S.
7. Salzman C, Schneider L, Alexopoulos G. Pharmacological treatment of depression in late life. In Bloom F, Kupfer D (eds), Psychopharmacology: The Fourth General of Progress. New York: Raven, 1995, 1771-7.
8. Robinson RG, Morris PH, Fedoroff JP. Depression and cerebrovascular disease. J Clin Psychiatry 1990; 51: 26-33.
9. Georgotas A, McCue RE, Hapworth W et al. Comparative efficacy and safety of MAOI vs. TCAs in treating depression in the elderly. Biol Psychiatry 1986; 21: 1155-66.
10. Lazarus LW, Groves L, Gierl B et al. Efficacy of phenelzine in geriatric depression. Biol Psychiatry 1986; 21: 699-701.
11. Pancheri P, Delle CR, Donnini M et al. Effects of moclobemide on depressive symptoms and cognitive performance in a geriatric population: a controlled comparative study vs. imipramine. Clin Neuropharmacol 1994; 17(suppl 1): 58-73S.
12. Nair NP, Amin M, Holm P et al. Moclobemide and nortriptyline in elderly depressed patients: a randomised multicentre trial against placebo. J Affect Disord 1995; 33: 1-9.
13. Roth M, Mountjoy CQ, Amrein R. The International Collaborative Study Group. Moclobemide placebo-controlled trial. Br J Psychiatry 1996; 16: 149-57.
14. Katona C. Current challenges faced by clinicians in managing late-life depression: what can be learnt from the recent evidence base? Mind Brain, in press.
15. Roose SP, Glassman AH, Attia E, Woodring S. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994; 151: 1735-9.
16. Mittmann N, Shear NH, Busto VE et al. Comparative evaluation of the efficacy and safety of tricyclic antidepressants and serotonin reuptake inhibitors in the elderly: a meta-analysis. Clin Invest Med 1994; 18: B53.
17. Nelson JC, Delucchi K, Schneider LS. Efficacy of secondgeneration antidepressants in late-life depression: a meta-analysis of the evidence. Am J Geriatr Psychiatry 2008; 16: 558-67.
18. Mukai Y, Tampi RR. Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants. Clin Ther 2009; 31: 945-61.
19. Sneed JR, Rutherford BR, Rindskopf D, Lane DT, Sackeim HA, Roose SP. Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry 2008; 16: 65-73.
20. Spigset O, Hedenmalm K. Hyponatremia in relation to treatment with antidepressants: a survey of reports in the World Health Organization database for spontaneous reporting of adverse drug reactions. Pharmacotherapy 1997; 17: 348-52.
21. Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996; 153: 311-20.
22. Preskorn SH. Reducing the risk of drug-drug interactions: a goal of rational drug development. J Clin Psychiatry 1996; 57(suppl 1): 3-6S.
23. Solai LK, Mulsant BH, Pollock BG et al. Effect of sertraline on plasma nortriptyline levels in depressed elderly. J Clin Psychiatry 1997; 58: 440-3.
24. Anon. Although adverse effects may occur, selective serotonin reuptake inhibitors are generally well tolerated in the elderly. Drugs Ther Perspect 2009; 25(5): 20-3.
25. Chemali Z, Chahine LM, Fricchione G. The use of selective serotonin reuptake inhibitors in elderly patients. Harv Rev Psychiatry 2009; 17(4): 242-53.
26. Smith AJ, Tett SE. How do different age groups use benzodiazepines and antidepressants: analysis of an Australian database 2003-6. Drugs Aging 2009; 26(2): 113-22.
27. Murphy E. The prognosis of depression and response to antidepressive therapies. Br J Psychiatry 1983; 142: 111-19.
28. Abou-Saleh MT, Coppen A. Classification of depression and response to anti-depressive therapies. Br J Psychiatry 1983; 143: 601-3.
29. Stoudemire A. Recurrence and relapse in geriatric depression: a review of risk factors and prophylactic treatment strategies. J Neuropsychiat 1997; 9: 209-21.
30. Reynolds CF. Treatment of depression in late life. Am J Med 1994; 97(suppl 6A): 39-46S.
31. Reynolds CF III, Frank E, Houck PR et al. Which elderly patients with remitted depression remain well with continued interpersonal psychotherapy after discontinuation of antidepressant medication? Am J Psychiatry 1997; 154: 958-62.
32. Flint AJ, Rifat SL. The effect of treatment on the two-year course of late-life depression. Br J Psychiatry 1997; 170: 268-72.
33. Lebowitz BD, Pearson JL, Schneider LS et al. Diagnosis and treatment of depression in late life: consensus statement update. J Am Med Assoc 1997; 278: 1186-90.
34. Reynolds CF, Frank E, Perel J et al. Maintenance therapies for late life recurrent major depression: research and review circa 1995. Int Psychogeriat 1995; 7(suppl): 27-40.
35. Reynolds CF III, Frank E et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 1999; 281(1): 39-45.
36. Reynolds CF III, Dew MA et al. Maintenance treatment of major depression in old age. N Engl J Med 2006; 354: 1130-8.
37. Klysner R, Bent-Hansen J, Hansen HL, et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy. Br J Psychiatry 2002; 181: 29-35.
38. Wilson KC, Mottram PG, Ashworth L, Abou-Saleh MT. Older community residents with depression: long-term treatment with sertraline. Randomised, double-blind, placebo-controlled study. Br J Psychiatry 2003; 182: 492-7.
39. Gorwood P, Weiller E, Lemming O, Katona C. Escitalopram prevents relapse in older patients with major depressive disorder. Am J Geriatr Psychiatry 2007; 15(7): 581-93.
40. Andreescu C, Lenze EJ, Dew EM, Begley AE. Effect of co-morbid anxiety on treatment response and relapse risk in late-life depression: controlled study. Br J Psychiatry 2007; 190: 344-9.
41. Coppen A, Abou-Saleh MT. Lithium therapy: from clinical trials to practical management. Acta Psychiatr Scand 1988; 78: 759-62.
42. Abou-Saleh MT. Long-term management of affective disorder. In Copeland JRM, Abou-Saleh MT, Blazer DG (eds), Principles and Practice of Geriatric Psychiatry, 1st edn. Chichester: Wiley, 1994, 587-96.
43. Coppen A. Depression as a lethal disease: prevention strategies. J Clin Psychiatry 1994; 55(suppl): 37-45.
44. Wilson KCM, Scott M, Abou-Saleh MT et al. Long-term effects of cognitive behavioural therapy and lithium therapy on depression in the elderly. Br J Psychiatry 1995; 167: 653-8.
45. Young RC. Bipolar mood disorders in the elderly. Geriat Psychiatry 1997; 20: 121-36.
46. Kusumakar V, Yatham LN, Haslam DRS et al. Treatment of mania, mixed state, and rapid cycling. Can J Psychiatry 1997; 42(suppl 2): 79-86S.
47. Yatham LN, Kusumakar V, Parikh SV et al. Bipolar depression: treatment options. Can J Psychiatry 1997; 42(suppl 2): 87-91S.
48. Goff DC, Jenike MA. Treatment-resistant depression in the elderly. J Am Geriat Soc 1986; 34: 63-70.
49. Kamholz BA, Mellow AM. Management of treatment resistance in the depressed geriatric patient. Psychiatry Clin North Am 1997; 19: 269-87.
50. Flint AJ, Rifat SL. Anxious depression in elderly patients. Response to antidepressant treatment. Am J Geriat Psychiatry 1997; 5: 107-15.
51. Georgotas A, Friedman E, McCarthy M et al. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors. Biol Psychiatry 1983; 18: 195-205.
52. Delgado PL, Price LH, Charney DS, Heninger GR. Efficacy of fluvoxamine in treatment-refractory depression. J Affect Disord 1988; 15: 55-60.
53. White K, Wykoff W, Tynes LL et al. Fluvoxamine in the treatment of tricyclic resistant depression. Psychiatry J Univ Ottawa 1990; 15: 156-8.
54. Brown WA, Harrison W. Are patients who are intolerant to one SSRI intolerant to another? Psychopharmacol Bull 1992; 28: 253-6.
55. Nierenberg AA, Feighner JP, Rudolph R et al. Venlafaxine for treatment-resistant unipolar depression. J Clin Psychopharmacol 1994; 14: 419-23.
56. Finch EJL, Katona CIE. Lithium augmentation in the treatment of refractory depression in old age. Int J Geriat Psychiatry 1989; 4: 41-6.
57. Flint AJ. Recent developments in geriatric psychopharmacotherapy. Can J Psychiatry 1994; 39(suppl 1): S9-18.
58. Zimmer B, Rosen J, Thornton JE et al. Adjunctive lithium carbonate in nortriptyline-resistant elderly depressed patients. J Clin Psychopharmacol 1991; 11: 254-6.
59. Flint AJ, Rifat SL. A prospective study of lithium augmentation in antidepressant-resistant geriatric depression. J Clin Psychopharmacol 1994; 14: 353-6.
60. Lafferman J, Solomon K, Ruskin P. Lithium augmentation for treatment-resistant depression in the elderly. J Geriat Psychiat Neurol 1998; 1: 49-52.
61. Reynolds CF III, Frank E, Perel JM et al. High relapse rate after discontinuation of adjunctive medication for elderly patients with recurrent major depression. Am J Psychiatry 1996; 153: 1418-22.
62. Flint AJ, Rifat SL The effect of sequential antidepressant treatment on geriatric depression. J Affect Disord 1996; 36(3-4): 95-105.
63. Sunderland T, Cohen RM, Molchan S et al. High-dose selegiline in treatment-resistant older depressive patients Arch Gen Psychiatry 1994; 51(8): 607-15.
64. Kok RM, Vink D, Heeren TJ et al. Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial. J Clin Psychiatry 2007; 68(8): 1177-85.
65. Freeman MP, Stott AL. Mood stabiliser combinations: a review of safety and efficacy. Am J Psychiatry 1998; 155: 12-21.
66. Rutherford B, Sneed J, Miyazaki M et al. An open trial of aripiprazole augmentation for SSRI non-remitters with late life depression. Int J Geriatr Psychiatry 2007; 22(10): 986-91.
67. Schneider AL, Wilcox CS. Divalproate augmentation in lithium resistant rapid cycling mania in four geriatric patients. J Affect Disord 1998; 47: 201-5.